This study demonstrated that a high FASN expression was associated with tumor size and HER2 positivity, but not associated with the histological grade, tumor stage, Ki-67 labeling index, estrogen receptor (ER) status, or progesterone receptor (PR) status. Here, ERBB2 is linked to neoplasm.